Abbott Drops Patent Claims Over Teva's Generic Simcor
Abbott Laboratories on Tuesday dropped five consolidated patent infringement suits against Teva Pharmaceuticals Industries Ltd. over Teva's attempts to market a generic version of Abbott's cholesterol drug Simcor....To view the full article, register now.
Already a subscriber? Click here to view full article